The Partnership for Research and Innovation in the Mediterranean Area (PRIMA) programme launches Calls to fund transnational R&I projects related to three main pillars: Water Management, Sustainable Farming Systems and the Agro-food Value Chain. Interested entities can either apply for EU-funded Section 1 projects or can apply for Member State-funded Section 2 projects for which each Participating State commits an annual budget. For 2022, Malta has committed EUR 500 000 to be availed of by Malta-based entities.

The Malta Council for Science and Technology (MCST) is committed to build capacity in writing effective and successful proposals submitted to PRIMA. In fact, MCST will be organising a full-day proposal writing workshop focussed on PRIMA proposals on the 10^th of January 2022. Training will be delivered by a key expert from the PRIMA Secretariat.

This workshop is intended for a broad range of stakeholders hailing from academia, public and private entities, NGOs, proposal writing service providers, funding support entities, end-users etc. Hence such a workshop can also be a useful opportunity to interact and build personal networks.

This event is by registration only and will be accessible both online and in-person. The number of in-person attendees is limited and so early registration is highly encouraged. Also, in-person attendees will need to present a valid COVID-19 vaccination certificate* and will need to consent to providing details for contact tracing purposes.

Venue: Main Hall, Villa Bighi, Kalkara

Date: 10^th January 2022

Time: 9.30am-5.00pm

Register here (for both in-person and online attendees)

Agenda: TBA

In-person attendees can register their interest to attend this workshop by the 31^st of December 2021 (limited places available). In-person attendees will receive a confirmatory email.

Deadline for registration to access the workshop online is 6^th of January 2021. Connection details/Meeting link will be provided prior to the workshop.

 * A valid vaccination certificate recognised by the Superintendent of Public Health for a full course of vaccination (2 doses or 1 dose of a single dose vaccine) with EMA approved vaccines (Comirnaty [Pfizer], Jannsen [Johnson & Johnson], Spikevax [Moderna], Vaxzevria [AstraZeneca]), with batches that are authorized by the national regulatory authority of the administering country, with 14 days after the last dose.